↓ Skip to main content

Dove Medical Press

Profile and Management of Toxicity of Selinexor and Belantamab Mafodotin for the Treatment of Triple Class Refractory Multiple Myeloma

Overview of attention for article published in Journal of Blood Medicine, July 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
13 Mendeley